Total glycosides of Rhodiola rosea L. attenuate LPS-induced acute lung injury by inhibiting TLR4/NF-κB pathway
Open Access
- 30 December 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 158, 114186
Abstract
No abstract availableKeywords
Funding Information
- National Science and Technology Major Project (2018ZX09735-005)
- Basic and Applied Basic Research Foundation of Guangdong Province (2019A1515110482)
- Basic and Applied Basic Research Foundation of Guangdong Province (2022071718149001)
- National Natural Science Foundation of China (82003580)
This publication has 33 references indexed in Scilit:
- Acute Lung Injury: Epidemiology, Pathogenesis, and TreatmentJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in miceAmerican Journal of Physiology-Renal Physiology, 2010
- Monoamine oxidase inhibition by Rhodiola rosea L. rootsJournal of Ethnopharmacology, 2009
- GSH and analogs in antiviral therapyMolecular Aspects of Medicine, 2009
- Has Mortality from Acute Respiratory Distress Syndrome Decreased over Time?: A Systematic ReviewAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung InjuryCell, 2008
- Nonventilatory Treatments for Acute Lung Injury and ARDSChest, 2007
- The role of Toll-like receptors in non-infectious lung injuryCell Research, 2006
- Analysis of the Marker Compounds of Rhodiola rosea L. (Golden Root) by Reversed Phase High Performance Liquid Chromatography.Chemical and Pharmaceutical Bulletin, 2001
- Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activityJournal of Pharmacological Methods, 1990